Medical Science Liaison-New York at Acadia Pharmaceuticals

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Advanced degree in a scientific or healthcare discipline (e.g., MD, DO, PharmD, PhD, DNP, PA-C)
Minimum 3 years of previous MSL experience in a pharmaceutical or biotech industry, preferably in a field-based medical role. Prior experience in Endocrinology preferred. Postdoctoral, academic, or government experience may be considered
Solid knowledge of clinical medicine, disease management, and medical research, ideally within hepatology or gastroenterology
Strong understanding of the US healthcare system, care delivery, and payer environment
Familiarity with FDA regulations, ICH/GCP guidelines, and legal considerations relevant to medical affairs and research
Proven ability to synthesize and communicate complex scientific data clearly and concisely to diverse audiences
Excellent project management, collaboration, and communication skills
Highly motivated and adaptable team player with the ability to work cross-functionally across commercial, clinical, and access teams
Proficient in digital tools including CRM platforms, Microsoft Office Suite, and virtual collaboration tools
Willingness to travel extensively (~60–70%), including occasional weekend commitments for scientific meetings

Responsibilities

Establish Madrigal’s presence and scientific leadership in MASH/NASH and chronic liver disease
Identify, develop, and maintain long-term collaborations with TLs, clinical investigators, and key stakeholders within the assigned geography
Deliver peer-to-peer, scientifically balanced exchanges on MASH/NASH disease state and Madrigal’s clinical programs and investigational therapies
Serve as a scientific expert to internal stakeholders, contributing to launch planning, field-based insights, and development of medical communication strategies
Provide scientific and strategic input for investigator-initiated trials, research collaborations, and site support in partnership with Clinical Development
Facilitate internal scientific training and contribute to speaker programs, advisory boards, and other medical affairs activities
Represent Madrigal at national and regional scientific and medical conferences, supporting booth activities and engaging with HCPs to capture real-world insights
Respond compliantly to unsolicited medical information requests, ensuring documentation aligns with internal processes and regulatory standards
Maintain strict compliance with applicable laws, industry codes, and company policies, with a strong grasp of US healthcare and regulatory environments

Skills

NASH

MASH

Endocrinology

Medical Science Liaison

Scientific Exchange

Thought Leader Engagement

Clinical Research

Investigator-Initiated Trials

Medical Affairs

Disease State Education

FDA Regulations

Phase 3 Trials

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free